Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Rezafungin in Intra-abdominal Candidiasis
NCT06985758Phase 4Completed
- Start
- Jan 2026
- Primary completion
- May 2026
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rezafungin in candidal peritonitis, Intra-abdominal candidiasis (IAC). Started Jan 2026; status: completed.
02
Drugs
rezafungin
03
Conditions
candidal peritonitisIntra-abdominal candidiasis (IAC)
Beyond the preview
Go deeper on NCT06985758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06985758.